Our Partnership Program...
LIG's Business Units & Linked Partnership Program
" High Quality Cost Effective Drug Development & Manufacturing Excellence World Wide "...
Fourteen years later* in 1987 Locum SA changed it's name and went international as Locum International, armed with some 200+ state-of-the-art key US/EU Generic Master Formula and Processes and tried and tested US and EU commercial manufacturing processes applicable to a wide variety of modern processing equipment. Nowadays all 200+ master formula and manufacturing processes are currently in full scale commercial and industrial production in over 65 countries, including the Africa, Asia, US, Canada and EU countries.
Hoechst RSA - Caps Zimbabwe, Wellcome, Ivax, Nortons, Reckitt and Colman, Zenith Goldline, Byk Gulden, Teva, Apotex, Novartis, Rhone Polenc Rorer, SKB etc. currently market today the same fruits of Locum's Generic and Innovative Research and Development as do many of Africa's state controlled manufacturing enterprises (Pharmacor - Eritrea, Kenya, South Africa etc.) See List
Locum has shown a remarkable capacity to create, recognize and respond to technological breakthroughs. The Group is organized into semiautonomous business units each aggressively pursuing technical advantages in generic and innovative modified release drug development and new product opportunities while honoring the time tested group's motto of: - " High Quality Cost Effective Drug Development & Manufacturing Excellence World Wide ".
Research and Development results and reviews are published on a regular basic through the groups extended scientific publishing house. LIG forte is generic development and scientific publishing.
The International Journal Series consists of eleven authoritative peer reviewed scientific monthly journals (Drug Development, R&D, Generic Drugs, Process Validation etc.) are industry leaders in their field and are read in almost every country in the world, where both generic and innovative drugs of quality are researched, developed, manufactured and marketed.
Locum Business units have harnessed via it's Partnership Program, and linked through IAGIM, development excellence and state-of-the-art CMC know-how in order to provide both diverse and rapidly developing capabilities by establishing an interrelated infrastructure that can respond quickly to ongoing changes in agency regulations and emerging generic technologies.
highly successful program offers a full inclusive consulting program
with the Ready-To-Go™ Series
of Know-how CMC applications (and dossiers) via rapid global e-mail,
Online and fax communication to the four corners of the earth.
Some highlights of the bilateral Partnership Program include:
Group is an unique multifaceted drug development, research, teaching,
distant learning and scientific publishing organization with an extended
global reach, fully focused on tomorrow's future in modern generic drug
development and state-of-the art technology.